Saturday, March 2

8:15 a.m. – Noon

Take 5!

Another round of expense reducers and revenue generators from pharmacy peers who will Take 5 minutes to tell you about something they do in their pharmacy that is working well for them and 10 minutes to interact, ask questions and offer suggestions.

NCPA’s Wildly Important Goals for Community Pharmacy

The community pharmacy environment is rapidly evolving, presenting new opportunities and challenges for independent pharmacy. NCPA CEO Doug Hoey will walk attendees through NCPA’s leadership strategy and plan for the year ahead and beyond. Special guest presenters will give context to the environment in which we will operate, including updates on Hill activity, practice transformation, and business opportunities for community pharmacy.

 

Advocating for a New Pharmacy Payment Model

From multiple visits to the White House and legislative wins, 2018 was a busy year for community pharmacy advocacy and 2019 should be no different. NCPA’s CEO and top advocacy staff will discuss the wins, the challenges, and the unknowns that have a significant impact on your business.

Presenter: NCPA CEO B. Douglas Hoey, Alexandria, Va.; Advocacy Director Karry La Violette, Alexandria, Va.

 

Practice Transformation and Business Opportunities

An update on CPESN® USA and Pharmacist eCare Plan activity.

 

Community Pharmacy from Another Lens: Diary of a Washington Insider

Ever wonder what leadership at government agencies are thinking? Hear the perceptions and potential for pharmacy from RADM Pamela Schweitzer’s firsthand experience providing leadership and coordination of PHS pharmacy programs and professional affairs for the Office of the Surgeon General and the Department of Health and Human Services.

Presenter: Former Assistant Surgeon General and 10th Chief Pharmacist Officer for the United State Public Health Service, Rear Admiral (ret) Pamela Schweitzer

 

Pharmacist and Pharmacy Technician Learning Objectives:

  1. Discuss three current legislative and regulatory issues that affect your independent, community pharmacy practice.
  2. Discuss at least three current initiatives toward improved change in the community pharmacy marketplace.
  3. Differentiate legal “scope of practice” from “clinical ability.”
  4. Describe common regulatory philosophies, including the “precautionary principle” and “permissionless innovation.”
  5. Describe advanced primary care medical home models that aim to strengthen primary care through multi-payer payment reform and care delivery transformation.